Latest Insider Transactions at Protagenic Therapeutics, Inc.New (PTIXW)
This section provides a real-time view of insider transactions for Protagenic Therapeutics, Inc.New (PTIXW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Protagenic Therapeutics, Inc.new to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Protagenic Therapeutics, Inc.new's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 12
2023
|
Alexander K. Arrow Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
8,000
+14.87%
|
$0
$0.81 P/Share
|
|
May 18
2022
|
Alexander K. Arrow Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
8,000
+5.02%
|
$0
$0.72 P/Share
|
|
May 17
2022
|
Alexander K. Arrow Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
23,000
+13.83%
|
$0
$0.71 P/Share
|
|
May 03
2021
|
Khalil Barrage Director |
BUY
Exercise of conversion of derivative security
|
Direct |
360,000
+26.55%
|
$360,000
$1.5 P/Share
|
|
Apr 30
2021
|
Alexander K. Arrow Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+0.82%
|
$2,000
$2.29 P/Share
|
|
Apr 29
2021
|
Alexander K. Arrow Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+0.83%
|
$2,000
$2.29 P/Share
|